sRAGE protects against AGE–RAGE-related pathologies, including vascular dysfunction and atherosclerosis, and obesity, by reducing AGE activity and signalling through the RAGE transmembrane effector [190,191]. Here, AGER is linked to obesity due to melanocortin 4 receptor deficiency.